Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by a variant in the GUCA1A gene, including cases diagnosed as cone dystrophy 3 or cone-rod dystrophy 14.
Biomarker and diagnostic research for GUCA1A-related retinopathy has been reported in the published literature.
No clinical trials have been registered for GUCA1A-related retinopathy.
4 publications have been identified in PubMed for GUCA1A-related retinopathy. Kisho has analyzed 3 by research type. Research spans Review / Meta-Analysis (67%) and Diagnostic / Biomarker (33%).
Allon G (2025). [PMID: 39969478](https://pubmed.ncbi.nlm.nih.gov/39969478/). *Invest Ophthalmol Vis Sci*. [Diagnostic / Biomarker]
Yang G (2025). [PMID: 40128064](https://pubmed.ncbi.nlm.nih.gov/40128064/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Wong WM (2025). [PMID: 40013354](https://pubmed.ncbi.nlm.nih.gov/40013354/). *Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 7:51 AM UTC
Common questions about GUCA1A-related retinopathy